相关实验视频

Updated: Jun 10, 2025

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

针对免疫治疗的瘤微环境的进展

Lugang Wang^1,2, Liubo Zhang¹, Zhen Zhang¹

¹Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.

Frontiers in immunology

|October 18, 2024

概括

瘤微环境 (TME) 抑制免疫反应,阻碍癌症治疗. 向和重塑TME可以增强宿主免疫系统,有效地对抗瘤.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
癌症生物学癌症生物学

背景情况:

瘤微环境 (TME) 对癌症的进展,入侵和转移至关重要.
TME表现出免疫抑制特征,包括缺氧,酸性,高间歇性压力和血管透性.
这些因素有助于免疫规避和免疫疗法效率降低.

研究的目的:

详细说明TME的特征和组成.
解释TME如何影响免疫监测.
总结TME调节的治疗策略.

主要方法:

对TME特征的文献综述.
在TME中分析免疫抑制成分.
针对TME调节的有针对性的治疗方法的综合.

主要成果:

TME具有多种免疫抑制特征,促进癌症生长.
这些特征造成了有效的抗瘤免疫反应的障碍.
准TME是一种有前途的策略,可以改善癌症免疫疗法.

结论:

了解TME的组成和功能是开发新癌症治疗的关键.
TME重塑可以克服免疫逃避并提高免疫治疗结果.
有针对性的TME监管提供了一种可行的方法来提高抗瘤免疫力.

关键词:

癌症癌症癌症癌症癌症免疫抑制是一种免疫抑制.免疫疗法免疫疗法有针对性的,有针对性的.瘤微环境是一个微环境.

更多相关视频

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

相关概念视频

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...